Atopic dermatitis
Conditions
Interventions
Test group:1 dose of Lianling Antipruritic Granules per day, taken twice for 2 weeks
Tacrolimus ointment, 2x/day, topical for 2 weeks
control group:Cetirizine hydrochloride tablets orally, once per night, 10mg once
2 weeks in total
Sponsors
The third Hospital affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-70 years old, gender is not limited; (2) Meets western medical diagnostic criteria for atopic dermatitis; (3) SCROAD score of mild to moderate at the initial diagnosis; (4) Meet the Chinese medicine diagnostic criteria for atopic dermatitis (Heart Fire and Spleen Deficiency); (5) No treatment related to atopic dermatitis, no systematic use or topical application of corticosteroids, no systematic application of immunosuppressants, biologics, etc. in the last 1 month; (6) Patients voluntarily participate in taking part in this clinical trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those whose lesions are combined with other skin diseases or serious infections; (2) Those who are allergic to the known drug components of Lian Ling Itch Relief Granules; (3) Patients who have participated in clinical trials of other drugs within the last 1 month. (4) Women who are pregnant, preparing for pregnancy or breastfeeding. (5) Patients with severe cardiovascular disease, diabetes mellitus, hypertension or severe immunocompromise; patients with chronic liver or kidney disease or other serious diseases;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| scoring atopic dermatitis,SCORAD; | — |
Secondary
| Measure | Time frame |
|---|---|
| Target skin lesion area;VAS;Chinese Medicine Symptom Score; | — |
Countries
CHINA
Contacts
Public Contactsun zhanxue
The third Hospital affiliated to Beijing University of Chinese Medicine
Outcome results
None listed